Redsense Medical AbNGM: REDS

REDS: Q2 sales fell 28% but H1 sales grew 6% year-over-year, with strong cash and new product launches

· Issued by Redsense Medical AB

Net sales declined 28% in Q2 2025, but H1 sales rose 6% year-over-year, with the US market contributing 99% of sales. The Redsense Clamp was CE marked and launched in new markets, while currency volatility and increased tariffs posed risks. Cash position remained strong at KSEK 14,692.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

Company analysis

Earlier from Redsense Medical Ab

All Redsense Medical Ab news releases